Still leaning towards retesting $54 before we see it retesting $90+. Largely based on US infection rates fast approaching critical 10% level. It seems likely that we will see a pull back in US equities based on negative short term outlook.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
